Skip to main content
Fig. 3 | BMC Complementary Medicine and Therapies

Fig. 3

From: Exploring the potential of Gonolobus condurango as a histone deacetylase inhibitor in triple-negative breast cancer cell lines: in vitro study

Fig. 3

Acetylation levels of HCC38 cells treated with GC Urtincture and different dilutions of GC. Histone acetylation of HCC38 after treatment with GC Urtincture, GC C30, GC C6, GC D6 or with TSA as a positive control. The results were normalized to the ethanol controls and the viability of cells measured by WST-1 assay. **P < 0.01, ***P < 0.001, 2-way ANOVA

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us